Pick Your Community: | Hopkins | Muhlenberg | Daviess | Christian | Fayette | Henderson | Lakes | McCracken | Warren | Webster

FDA Approves Ragwitek for Short Ragweed Pollen Allergies

spring-allergiesKENTUCKY (4/17/14) — The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflammation), in adults 18 years through 65 years of age.

Ragwitek contains an extract from short ragweed (Ambrosia artemisiifolia) pollen. It is a tablet that is taken once daily by placing it sublingually, where it rapidly dissolves. Treatment with Ragwitek is started 12 weeks before the start of ragweed pollen season and continued throughout the season. The first dose is taken in a health care professional’s office where the patient is to be observed for at least 30 minutes for potential adverse reactions. After the first dose, patients can take Ragwitek at home.

“The approval of Ragwitek offers millions of adults living with ragweed pollen allergies in the United States an alternative to allergy shots to help manage their disease,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research.

Individuals with allergic rhinitis with or without conjunctivitis may experience a runny nose, repetitive sneezing, nasal itching, nasal congestion, and itchy and watery eyes. Short ragweed pollen is one of the most common seasonal allergens and is prevalent during the late summer and early fall months in most of the United States. Short ragweed pollen induced allergies are generally managed by avoiding the allergen, medications to relieve symptoms, or with allergy shots.

The safety and effectiveness of Ragwitek was evaluated in studies conducted in the United States and internationally. Safety was assessed in approximately 1,700 adults. The most commonly reported adverse reactions by patients treated with Ragwitek were itching in the mouth and ears and throat irritation. Of the 1,700 adults, about 760 were evaluated to determine effectiveness. Some patients received Ragwitek; others received an inactive substitute (placebo). The patients reported their symptoms and additional medications needed to get through the allergy season. During treatment for one ragweed pollen season, patients who received Ragwitek experienced approximately a 26 percent reduction in symptoms and the need for medications compared to those who received a placebo.

The Prescribing Information includes a boxed warning to inform that severe allergic reactions, some of which can be life threatening, can occur. Ragwitek also has a Medication Guide for distribution to the patient.

Ragwitek is manufactured for Merck, Sharp & Dohme Corp., (a subsidiary of Merck and Co., Inc., Whitehouse Station, N.J.) by Catalent Pharma Solutions Limited, United Kingdom. For more information: Allergenics.

Read more on SurfKY about allergies:

Spring Allergies May Come From Everyday Things

Scoping It Out: Spring is Here, Do You Have the Fever?

SurfKY News
Information provided by FDA

© Copyright 2014 SurfKY News Group, Inc. All rights reserved. This material may not be published, broadcast, or rewritten without permission. SurfKY News encourages you to share this story by using one of the social media links below.

Most Read This Week (Site-Wide)

August 25, 2014 4954

Flooded Central City Church's Seven Day…

in Top Stories by Paul McRee, SurfKY News
August 25, 2014 4442

14-Year-Old Suffers Gunshot Wound; Air…

in Top Stories by Ami Clayton, SurfKY News
August 25, 2014 4308

Camper Stolen in Utica Recovered in…

in Top Stories by Martha Clark
August 25, 2014 3884

44th Mount Saint Joseph Picnic is Sunday,…

in News by Jennifer Kaminski
August 25, 2014 3795

Daviess County Health Department…

in News by Dennis Beard, SurfKY News

Most Read Stories from Hopkins County

August 25, 2014 4442

14-Year-Old Suffers Gunshot Wound; Air…

in Top Stories by Ami Clayton, SurfKY News
August 25, 2014 2529

Two Injured in Two-Vehicle Collision Near…

in Top Stories by Trooper Stu Recke
August 25, 2014 2441

Former Co-Workers Trying to Raise Money…

in Top Stories by Rita Dukes Smith, SurfKY News Director
August 26, 2014 1951

Two People Injured When Vehicle Overturns…

in Top Stories by Matt Sanderson
August 27, 2014 1299

Crime Stoppers Top Most Wanted - August…

in Top Stories by Crime Stoppers

Most Read Stories from Owensboro

August 25, 2014 3884

44th Mount Saint Joseph Picnic is Sunday,…

in News by Jennifer Kaminski
August 25, 2014 3795

Daviess County Health Department…

in News by Dennis Beard, SurfKY News
August 25, 2014 3675

GRADD Seeking Ombudsman Program Volunteers

in News by Woody Maglinger
August 26, 2014 3378

Owensboro Board of Commissioners…

in News by Beth Cecil
August 26, 2014 2941

City Street Closures on Strawbridge and…

in News by Abby Shelton

Most Read Stories from Muhlenberg County

August 25, 2014 4954

Flooded Central City Church's Seven Day…

in Top Stories by Paul McRee, SurfKY News
August 25, 2014 4308

Camper Stolen in Utica Recovered in…

in Top Stories by Martha Clark
August 25, 2014 3595

Job Corp Celebrates 50th Anniversary

in Top Stories by Charles W. Riley II, SurfKY News
August 25, 2014 3509

Mustangs Marching Classic

in Top Stories by Charles W. Riley II, SurfKY News
August 26, 2014 3080

Family Has Close Call with Tornado

in Top Stories by Paul McRee, SurfKY News

SurfKY News Group, Inc. Central Office & Printing Division
1125 Nebo Rd.  •  Madisonville, KY 42431  •  270.452.2249 (fax)
Main Number: 270.452.2727 (phone)  •  Printing Division Direct Line: 270.821.8600 (phone)

SurfKY Owensboro News Bureau
920 Frederica St. / Suite 210  •  Owensboro, KY 42301  •  270.683-8060 (phone)


Contact a member of our staff: www.surfky.com/contact
Copyright © 2014 SurfKY News Group, Inc.  •  Terms of Use  •  Site Map

social 03social 04social 22social 21social 06